Yahoo Web Search

Search results

1. • 

     Sen. Sanders investigates high cost of obesity drugs Ozempic and Wegovy

     WCAX-TV Vermont· 3 hours ago

     Vermont Senator Bernie Sanders this week launched an investigation into the pricing of Ozempic and...

2. • 

     Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?

     USA TODAY· 1 day ago

     The costs have increased so rapidly, even before Medicare plans are allowed to cover these drugs for...

3. • 

     Sanders launches Senate investigation into ‘outrageously high’ pricing of Ozempic, Wegovy

     CNN via Yahoo News· 1 day ago

     The Vermont senator, an independent who has long called out drug manufacturers for their costly...

4. • 

     Fact check: Biden is right about $35 insulin cap but exaggerates prior costs for Medicare enrollees

     Medical Xpress· 2 weeks ago

     The cost of insulin in the United States has risen considerably in recent years, with some estimates...

5. • New Favorable OIG Advisory Opinion Allows Patient Assistant Programs Funded by Drug Manufacturers |...

     JD Supra· 16 hours ago

     The OIG has previously recognized the importance of PAPs to mitigate the increasing cost of prescription drugs as long as these PAPs do not implicate the federal anti-kickback statute, the civil ...

6. • 

     1 in 4 Medicare beneficiaries with obesity could get Wegovy despite coverage ban

     The Hill via Yahoo News· 3 days ago

     An estimated 3.6 million Medicare beneficiaries could potentially access Wegovy since the Food and ...

7. • 

     Law Digest - 4th Circuit - April 18, 2024 - Maryland Daily Record

     The Daily Record· 1 week ago

     BOTTOM LINE: Where a drug manufacturer challenged a regulation that set forth criteria for what...

8. • Medicare Advantage insurers mull Wegovy coverage ‘trade-offs’

     Modern Healthcare· 2 days ago

     Medicare Advantage insurers are weighing coverage of pricey new anti-obesity drugs after federal regulators last month announced traditional Medicare would ...

9. • ... Week in Review: HHS Finalizes 340B ADR Rule; House and Senate Hold Hearings on President’s FY...

     JD Supra· 5 days ago

     Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance;...

10. • HHS Proposes Rule to Eliminate Safe Harbor for PBM Drug Rebates

      The National Law Review· 2 weeks ago

      ...discounts relating to price reductions or other remuneration offered by a pharmaceutical manufacturer to a Medicare Part D plan sponsor (“Plan Sponsor”), a Medicaid managed care organization (“MCO”), and/or a pharmacy benefit manager (“PBM”) under contract with such a sponsor...the most...